MedTrace Logo

Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography

NCT03783832 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2018-12-21

No results posted yet for this study

Summary

This is a non-interventional, longitudinal, retrospective and prospective, non-controlled, single arm study in naive or non-naive patients with diabetic macular edema for which aflibercept (EYLEA®) therapy is indicated.

Conditions

Interventions

OTHER

OCT ANGIOGRAPHY DATA

Follow-up of diabetic macular edema treated by Aflibercept (EYLEA®) with OCT angiography

Sponsors & Collaborators

  • Aquitania Opthalmologica

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-19
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03783832 on ClinicalTrials.gov